2-[[(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-carboxycyclohex-3-en-1-yl]methoxy]pyridine-3-carboxylic acid;(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-[(3-cyano-2-pyridinyl)oxymethyl]cyclohex-3-ene-1-carboxylic acid

C92H127N5O14 — CID 158515619

IUPAC2-[[(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-carboxycyclohex-3-en-1-yl]methoxy]pyridine-3-carboxylic acid;(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-[(3-cyano-2-pyridinyl)oxymethyl]cyclohex-3-ene-1-carboxylic acid
SMILESC=C(C)[C@@H]1CC[C@]2(NC[C@@H](O)C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC=C(C6=CC[C@](COc7ncccc7C#N)(C(=O)O)CC6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.C=C(C)[C@@H]1CC[C@]2(NC[C@@H](O)C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC=C(C6=CC[C@](COc7ncccc7C(=O)O)(C(=O)O)CC6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12
InChIInChI=1S/C46H63N3O6.C46H64N2O8/c1-28(2)31-14-21-46(49-26-34(50)39(51)52)23-22-43(6)33(37(31)46)10-11-36-42(5)17-15-32(41(3,4)35(42)16-18-44(36,43)7)29-12-19-45(20-13-29,40(53)54)27-55-38-30(25-47)9-8-24-48-38;1-27(2)29-14-21-46(48-25-33(49)39(52)53)23-22-43(6)32(36(29)46)10-11-35-42(5)17-15-31(41(3,4)34(42)16-18-44(35,43)7)28-12-19-45(20-13-28,40(54)55)26-56-37-30(38(50)51)9-8-24-47-37/h8-9,12,15,24,31,33-37,49-50H,1,10-11,13-14,16-23,26-27H2,2-7H3,(H,51,52)(H,53,54);8-9,12,15,24,29,32-36,48-49H,1,10-11,13-14,16-23,25-26H2,2-7H3,(H,50,51)(H,52,53)(H,54,55)/t31-,33+,34+,35-,36+,37+,42-,43+,44+,45-,46-;29-,32+,33+,34-,35+,36+,42-,43+,44+,45-,46-/m00/s1
InChIKeyHLOYVVHXHBLESI-YQRVZTJBSA-N
MW1527.05 g/mol
LogP16.82
Rot. Bonds21

About 2-[[(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-carboxycyclohex-3-en-1-yl]methoxy]pyridine-3-carboxylic acid;(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-[(3-cyano-2-pyridinyl)oxymethyl]cyclohex-3-ene-1-carboxylic acid

2-[[(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-carboxycyclohex-3-en-1-yl]methoxy]pyridine-3-carboxylic acid;(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-[(3-cyano-2-pyridinyl)oxymethyl]cyclohex-3-ene-1-carboxylic acid (PubChem CID 158515619) has the molecular formula C92H127N5O14 and a molecular weight of 1527.05 g/mol. Its IUPAC name is 2-[[(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-carboxycyclohex-3-en-1-yl]methoxy]pyridine-3-carboxylic acid;(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-[(3-cyano-2-pyridinyl)oxymethyl]cyclohex-3-ene-1-carboxylic acid.

Molecular Properties

Compound Name2-[[(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-carboxycyclohex-3-en-1-yl]methoxy]pyridine-3-carboxylic acid;(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-[(3-cyano-2-pyridinyl)oxymethyl]cyclohex-3-ene-1-carboxylic acid
PubChem CID158515619
Molecular FormulaC92H127N5O14
Molecular Weight1527.05 g/mol
Exact Mass1525.94
IUPAC Name2-[[(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-carboxycyclohex-3-en-1-yl]methoxy]pyridine-3-carboxylic acid;(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-[(3-cyano-2-pyridinyl)oxymethyl]cyclohex-3-ene-1-carboxylic acid
SMILESC=C(C)[C@@H]1CC[C@]2(NC[C@@H](O)C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC=C(C6=CC[C@](COc7ncccc7C#N)(C(=O)O)CC6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.C=C(C)[C@@H]1CC[C@]2(NC[C@@H](O)C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC=C(C6=CC[C@](COc7ncccc7C(=O)O)(C(=O)O)CC6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12
InChIInChI=1S/C46H63N3O6.C46H64N2O8/c1-28(2)31-14-21-46(49-26-34(50)39(51)52)23-22-43(6)33(37(31)46)10-11-36-42(5)17-15-32(41(3,4)35(42)16-18-44(36,43)7)29-12-19-45(20-13-29,40(53)54)27-55-38-30(25-47)9-8-24-48-38;1-27(2)29-14-21-46(48-25-33(49)39(52)53)23-22-43(6)32(36(29)46)10-11-35-42(5)17-15-31(41(3,4)34(42)16-18-44(35,43)7)28-12-19-45(20-13-28,40(54)55)26-56-37-30(38(50)51)9-8-24-47-37/h8-9,12,15,24,31,33-37,49-50H,1,10-11,13-14,16-23,26-27H2,2-7H3,(H,51,52)(H,53,54);8-9,12,15,24,29,32-36,48-49H,1,10-11,13-14,16-23,25-26H2,2-7H3,(H,50,51)(H,52,53)(H,54,55)/t31-,33+,34+,35-,36+,37+,42-,43+,44+,45-,46-;29-,32+,33+,34-,35+,36+,42-,43+,44+,45-,46-/m00/s1
InChIKeyHLOYVVHXHBLESI-YQRVZTJBSA-N
XLogP16.82
TPSA319.05 Ų
H-Bond Donors9
H-Bond Acceptors14
Rotatable Bonds21
Heavy Atoms111
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001527.05
LogP ≤ 516.82
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze 2-[[(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-carboxycyclohex-3-en-1-yl]methoxy]pyridine-3-carboxylic acid;(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-[(3-cyano-2-pyridinyl)oxymethyl]cyclohex-3-ene-1-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[[(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-carboxycyclohex-3-en-1-yl]methoxy]pyridine-3-carboxylic acid;(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-[(3-cyano-2-pyridinyl)oxymethyl]cyclohex-3-ene-1-carboxylic acid?
The IUPAC name of 2-[[(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-carboxycyclohex-3-en-1-yl]methoxy]pyridine-3-carboxylic acid;(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-[(3-cyano-2-pyridinyl)oxymethyl]cyclohex-3-ene-1-carboxylic acid (CID 158515619) is 2-[[(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-carboxycyclohex-3-en-1-yl]methoxy]pyridine-3-carboxylic acid;(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-[(3-cyano-2-pyridinyl)oxymethyl]cyclohex-3-ene-1-carboxylic acid.
What is the SMILES notation for 2-[[(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-carboxycyclohex-3-en-1-yl]methoxy]pyridine-3-carboxylic acid;(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-[(3-cyano-2-pyridinyl)oxymethyl]cyclohex-3-ene-1-carboxylic acid?
The canonical SMILES for 2-[[(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-carboxycyclohex-3-en-1-yl]methoxy]pyridine-3-carboxylic acid;(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-[(3-cyano-2-pyridinyl)oxymethyl]cyclohex-3-ene-1-carboxylic acid is C=C(C)[C@@H]1CC[C@]2(NC[C@@H](O)C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC=C(C6=CC[C@](COc7ncccc7C#N)(C(=O)O)CC6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.C=C(C)[C@@H]1CC[C@]2(NC[C@@H](O)C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC=C(C6=CC[C@](COc7ncccc7C(=O)O)(C(=O)O)CC6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.
What is the InChIKey of 2-[[(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-carboxycyclohex-3-en-1-yl]methoxy]pyridine-3-carboxylic acid;(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-[(3-cyano-2-pyridinyl)oxymethyl]cyclohex-3-ene-1-carboxylic acid?
The InChIKey is HLOYVVHXHBLESI-YQRVZTJBSA-N. The full InChI is InChI=1S/C46H63N3O6.C46H64N2O8/c1-28(2)31-14-21-46(49-26-34(50)39(51)52)23-22-43(6)33(37(31)46)10-11-36-42(5)17-15-32(41(3,4)35(42)16-18-44(36,43)7)29-12-19-45(20-13-29,40(53)54)27-55-38-30(25-47)9-8-24-48-38;1-27(2)29-14-21-46(48-25-33(49)39(52)53)23-22-43(6)32(36(29)46)10-11-35-42(5)17-15-31(41(3,4)34(42)16-18-44(35,43)7)28-12-19-45(20-13-28,40(54)55)26-56-37-30(38(50)51)9-8-24-47-37/h8-9,12,15,24,31,33-37,49-50H,1,10-11,13-14,16-23,26-27H2,2-7H3,(H,51,52)(H,53,54);8-9,12,15,24,29,32-36,48-49H,1,10-11,13-14,16-23,25-26H2,2-7H3,(H,50,51)(H,52,53)(H,54,55)/t31-,33+,34+,35-,36+,37+,42-,43+,44+,45-,46-;29-,32+,33+,34-,35+,36+,42-,43+,44+,45-,46-/m00/s1.
What are the key properties of 2-[[(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-carboxycyclohex-3-en-1-yl]methoxy]pyridine-3-carboxylic acid;(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-[(3-cyano-2-pyridinyl)oxymethyl]cyclohex-3-ene-1-carboxylic acid?
2-[[(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-carboxycyclohex-3-en-1-yl]methoxy]pyridine-3-carboxylic acid;(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-[(3-cyano-2-pyridinyl)oxymethyl]cyclohex-3-ene-1-carboxylic acid has a molecular weight of 1527.05 g/mol, XLogP of 16.82, 21 rotatable bonds, 9 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[[(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-carboxycyclohex-3-en-1-yl]methoxy]pyridine-3-carboxylic acid;(1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[[(2R)-2-carboxy-2-hydroxyethyl]amino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-[(3-cyano-2-pyridinyl)oxymethyl]cyclohex-3-ene-1-carboxylic acid is sourced from PubChem (CID 158515619), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).